原料药(API)

原料药(API)

53 个产品

原料药与多肽,纯度 ≥99%,经审核合格的合作工厂供应。可随批提供 COA 与 MSDS。

结构图CAS 号产品名称细分类含量
Abemaciclib,LY2835219 structure1231929-97-7Abemaciclib,LY2835219抗肿瘤原料药99%
Acalabrutinib, ACP-196 CAS NO.:1420477-60-6 structure1420477-60-6Acalabrutinib, ACP-196 CAS NO.:1420477-60-6抗肿瘤原料药99%
Afatinib Dimaleate structure850140-73-7Afatinib Dimaleate抗肿瘤原料药99%
Alectinib Hydrochloride structure1256589-74-8Alectinib Hydrochloride抗肿瘤原料药99%
Axitinib structure319460-85-0Axitinib抗肿瘤原料药99%
Cabozantinib Malate structure1140909-48-3Cabozantinib Malate抗肿瘤原料药99%
Crizotinib structure877399-52-5Crizotinib抗肿瘤原料药99%
Dacomitinib structure1110813-31-4Dacomitinib抗肿瘤原料药99%
Galunisertib structure700874-72-2Galunisertib抗肿瘤原料药99%
Ibrutinib structure936563-96-1Ibrutinib抗肿瘤原料药99%
Larotrectinib Sulfate structure1223405-08-0Larotrectinib Sulfate抗肿瘤原料药99%
Lenvatinib Mesylate structure857890-39-2Lenvatinib Mesylate抗肿瘤原料药99%
Lorlatinib structure1454846-35-5Lorlatinib抗肿瘤原料药99%
Neratinib Maleate structure915942-22-2Neratinib Maleate抗肿瘤原料药99%
Nintedanib Ethanesulfonate structure656247-18-6Nintedanib Ethanesulfonate抗肿瘤原料药99%
Niraparib structure1038915-60-4Niraparib抗肿瘤原料药99%
Niraparib Tosylate Monohydrate structure1613220-15-7Niraparib Tosylate Monohydrate抗肿瘤原料药99%
Olaparib structure763113-22-0Olaparib抗肿瘤原料药99%
Osimertinib Mesylate structure1421373-66-1Osimertinib Mesylate抗肿瘤原料药99%
Pazopanib Hydrochloride structure635702-64-6Pazopanib Hydrochloride抗肿瘤原料药99%
Ponatinib Hydrochloride structure1114544-31-8Ponatinib Hydrochloride抗肿瘤原料药99%
Poziotinib structure1092364-38-9Poziotinib抗肿瘤原料药99%
Regorafenib Hydrate structure1019206-88-2Regorafenib Hydrate抗肿瘤原料药99%
Ribociclib Succinate structure1374639-75-4Ribociclib Succinate抗肿瘤原料药99%
Ruxolitinib Phosphate structure1092939-17-7Ruxolitinib Phosphate抗肿瘤原料药99%
Temozolomide structure85622-93-1Temozolomide抗肿瘤原料药99%
Vandetanib structure443913-73-3Vandetanib抗肿瘤原料药99%
Veliparib structure912444-00-9Veliparib抗肿瘤原料药99%
Veliparib dihydrochloride structure912445-05-7Veliparib dihydrochloride抗肿瘤原料药99%
Vemurafenib structure918504-65-1Vemurafenib抗肿瘤原料药99%
Alogliptin benzoate structure850649-62-6Alogliptin benzoate抗糖尿病原料药99%
Dapagliflozin structure461432-26-8Dapagliflozin抗糖尿病原料药99%
Empagliflozin structure864070-44-0Empagliflozin抗糖尿病原料药99%
Ertugliflozin L-Pyroglutamic Acid structure1210344-83-4Ertugliflozin L-Pyroglutamic Acid抗糖尿病原料药99%
Linagliptin structure668270-12-0Linagliptin抗糖尿病原料药99%
Sotagliflozin structure1018899-04-1Sotagliflozin抗糖尿病原料药99%
Trelagliptin Succinate structure1029877-94-8Trelagliptin Succinate抗糖尿病原料药99%
Glecaprevir structure1365970-03-1Glecaprevir抗肝炎原料药99%
Obeticholic Acid structure459789-99-2Obeticholic Acid抗肝炎原料药99%
Pibrentasvir structure1353900-92-1Pibrentasvir抗肝炎原料药99%
Simeprevir Sodium structure1241946-89-3Simeprevir Sodium抗肝炎原料药99%
Sofosbuvir structure1190307-88-0Sofosbuvir抗肝炎原料药99%
Tenofovir Alafenamide Fumarate structure1392275-56-7Tenofovir Alafenamide Fumarate抗肝炎原料药99%
Velpatasvir structure1377049-84-7Velpatasvir抗肝炎原料药99%
Baricitinib structure1187594-09-7Baricitinib抗风湿原料药99%
Methotrexate structure59-05-2Methotrexate抗风湿原料药99%
Tofacitinib Citrate structure540737-29-9Tofacitinib Citrate抗风湿原料药99%
Upadacitinib structure1310726-60-3Upadacitinib抗风湿原料药99%
Atosiban Acetate structure90779-69-4Atosiban Acetate多肽类99%
Glutathione structure70-18-8Glutathione多肽类99%
Octreotide Acetate structure83150-76-9Octreotide Acetate多肽类99%
Plecanatide structure467426-54-6Plecanatide多肽类99%
Terlipressin Acetate structure14636-12-5Terlipressin Acetate多肽类99%
质量与文件——每批随附 COA(HPLC 纯度与杂质谱);含手性中心的品种提供手性 HPLC 数据;可按需提供 ICH Q3C/Q3D 口径的残留溶剂与元素杂质数据;首批货物附 NMR 与 MS 结构确证;SDS 按目标市场语言与 GHS 分类提供。

没有找到需要的原料药?我们可按需调取更广的中国原料药与多肽资源——提供 CAS 号或 INN 名,我们会确认可供性、文件与交期。

提交需求